Search Results 61-70 of 18459 for total bilirubin

1. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

   Serum total bilirubin. ≤ 1.5 X ULN OR Direct bilirubin ≤ ULN for subjects with total bilirubin levels > 1.5 ULN. AST (SGOT) and ALT (SGPT). ≤ 2.5 X ULN ...

2. A Study of a Personalized Neoantigen Cancer Vaccine - Mayo Clinic

   Total bilirubin ≤ 1.5 × ULN OR direct bilirubin ≤ 1 × ULN (patients with Gilbert's disease may be included if their total bilirubin is ≤ 3.0 mg/dL); ...

3. Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia - Mayo Clinic

   Total and direct bilirubin < ULN at Screening. Exclusion Criteria: 1. Treatment within 2 days prior to screening with oral iron or iron-containing

4. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

   * Total bilirubin ≤ 1.5 X ULN OR Direct bilirubin ≤ ULN for subjects with total bilirubin levels \> 1.5 ULN OR total bilirubin ≤ 2 x ULN if liver ...

5. Phase IIb Study of Dasatinib Versus Imatinib in Patients With CML-CP Who Have Not Achieved an Early Optimal Response to Imatinib - Mayo Clinic

   ... serum creatinine ≤ 3 times the institutional upper limit of normal (ULN); Adequate hepatic function defined as: Total Bilirubin ≤2.0 times institutional ULN ...

6. A Study to Evaluate Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers - Mayo Clinic

   Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (except patients with Gilbert?s syndrome, who must have a direct bilirubin < 1.5 mg/dL) ...

7. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss - Mayo Clinic

   Have a serum total bilirubin ≤ 1.5 × upper limit of normal (ULN). Have an alanine aminotransferase (ALT) ≤ 3.0 × ULN. Note: There are no specific ...

8. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

   Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) OR, if total bilirubin is > 1.5 x ULN, the direct bilirubin must be normal; SGOT (AST) ...

9. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

   Total bilirubin ≥ 1.5 times the ULN; subjects with a history of Gilbert's syndrome may have a direct bilirubin measured and would be eligible for this ...

10. Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients - Mayo Clinic

    Total bilirubin >1.5 × ULN (may be repeated if 1.5–3 × ULN). Total bilirubin >2 × ULN, in case that gilbert's syndrome can be confidently diagnosed, which ...